IE
SONM icon

Israel Englander’s DNA X Inc SONM Stock Holding History

Israel Englander’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-161
Closed -$17.6K – 6488
2024
Q1 		$17.6K Buy
161
+37
+30% +$4.55K ﹤0.01% 5837
2023
Q4 		$16.4K Sell
124
-102
-45% -$13.5K ﹤0.01% 5665
2023
Q3 		$27.5K Buy
+226
New +$31.5K ﹤0.01% 5586
2023
Q2 		– Sell
-254
Closed -$46K – 6650
2023
Q1 		$46K Sell
254
-608
-71% -$57.1K ﹤0.01% 5652
2022
Q4 		$66K Buy
862
+637
+283% +$52.4K ﹤0.01% 5711
2022
Q3 		$20K Sell
225
-339
-60% -$42.1K ﹤0.01% 6463
2022
Q2 		$56K Buy
+564
New +$63.7K ﹤0.01% 6157
2021
Q1 		– Sell
-23
Closed -$30K – 6469
2020
Q4 		$30K Sell
23
-144
-86% -$157K ﹤0.01% 5115
2020
Q3 		$234 Buy
167
+45
+37% +$72.3K ﹤0.01% 3993
2020
Q2 		$178K Buy
+122
New +$195K ﹤0.01% 3874
2019
Q4 		– Sell
-26
Closed -$135K – 4604
2019
Q3 		$135K Buy
26
+15
+136% +$230K ﹤0.01% 3896
2019
Q2 		$241K Buy
+11
New +$279K ﹤0.01% 3670

Other funds holding SONM

SA
Sicart Associates New York $408M AUM 38.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.78B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Israel Englander's SONM Position: Q2 2024 in Review

Israel Englander sold out of DNA X Inc (SONM) in Q2 2024, closing a stake of 161 shares — an estimated $17.6K sold.

Israel Englander first reported a position in SONM in Q2 2019 and held it in 12 quarters. The position peaked at $241K in Q2 2019. 15 funds tracked by Wall St. Rank hold SONM as of Q2 2024.

  • Israel Englander reported no remaining DNA X Inc position as of Q2 2024 after selling out during the quarter.
  • Israel Englander sold 161 DNA X Inc shares in Q2 2024, an estimated $17.6K.
  • Israel Englander first reported a position in DNA X Inc in Q2 2019 and held it in 12 quarters.
  • Israel Englander's DNA X Inc position peaked at $241K in Q2 2019.
  • 15 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.